The 20 Best Cholangiocarcinoma (Bile Duct Cancer) Doctors Near Me in Michigan, US

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Dr. Sahai is the Leader of the Gastrointestinal Medical Oncology Section and Associate Professor in the Division of Hematology-Oncology, Department of Internal Medicine. Dr. Sahai is also a member of the University of Michigan Rogel Cancer Center and Director of Tumor Response Assessment Core.Dr. Sahai attended medical school at the Government Medical College at Amritsar with the Baba Farid University of Health Science in India. He then completed his Masters in Clinical Epidemiology at Harvard School of Public Health followed by Internal Medicine residency training at University of Pittsburgh where he met his wife. He completed his fellowship in Hematology-Oncology at Northwestern University where he also served as the Chief Fellow. Subsequently, Dr. Sahai joined University of Michigan as Assistant Professor in Internal Medicine in 2013.Dr. Sahai is a clinician-scientist who sees patients within the Multidisciplinary Pancreatic and Liver Tumor programs. As a clinical investigator he is the Principal Investigator on several investigator-initiated clinical trials open across the U.S. His translational research program leverages the pancreaticobiliary cancer biobanks that he directs for the therapeutic investigation of novel compounds in patient-derived cell lines and xenograft models to help develop novel phase 1/2 investigator-initiated clinical trials. Dr. Sahai is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Sreenivasa Chandana is a Hematologist Oncology specialist and an Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 22 years. Dr. Chandana is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Familial Colorectal Cancer, Endoscopy, and Pancreatectomy. Dr. Chandana is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Chandana is currently accepting new patients.

Mishal Mendiratta is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Mendiratta is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Visceromegaly, and Cholangiocarcinoma (Bile Duct Cancer).

Laith Jamil is a Gastroenterologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 34 years. Dr. Jamil is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Hereditary Pancreatitis, Endoscopy, and Sleeve Gastrectomy. Dr. Jamil is board certified in American Board Of Internal Medicine. Dr. Jamil is currently accepting new patients.

Bradley Krasnick is a Colorectal Surgeon practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 12 years. Dr. Krasnick is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pancreatic Islet Cell Tumor, Gallbladder Cancer, Gallbladder Disease, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery. Dr. Krasnick is board certified in American Board Of Colon And Rectal Surgery and American Board Of Surgery. Dr. Krasnick is currently accepting new patients.

Gehad Ghaith is a Gastroenterologist practicing medicine in Troy, Michigan. He has been practicing medicine for over 29 years. Dr. Ghaith is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Cholestasis, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Gastrectomy. Dr. Ghaith is board certified in American Board Of Internal Medicine. Dr. Ghaith is currently accepting new patients.

Jonathan Olsen is a Radiologist and an Interventional Radiologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 16 years. Dr. Olsen is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, Ascites, Bone Marrow Aspiration, and Vertebroplasty. Dr. Olsen is board certified in American Board Of Radiology. Dr. Olsen is currently accepting new patients.

George Howard is an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 24 years. Dr. Howard is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 113 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Familial Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Gastrostomy. Dr. Howard is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Howard is currently accepting new patients.

Thomas Enzler, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology. He received his Master of Science from ETH Zurich and his Medical Degree from University of Basel, Switzerland. After completion of residency in Internal Medicine at University Hospitals of Zurich and Basel, Dr. Enzler did a research fellowship at the Dana Farber Cancer Institute, Harvard Medical School, Boston. There, he worked on projects focusing on tumor immune surveillance and his work resulted in several publications and in a PhD ‘magna cum laude’ in Biochemistry/Immunology (Harvard Medical School Boston/Max Delbrueck Center Berlin). He then moved to University of California San Diego to study signaling pathways of cancer cells and immune cells. While there, he successfully obtained ECFMG certification prior to doing clinic and laboratory research at Stanford University. From California Dr. Enzler went to Germany to do a Hematology and Oncology fellowship at University of Goettingen and he received board certification in both in Germany and in Switzerland. Dr. Enzler decided to return to the U.S. and completed U.S. residency in Internal Medicine at University of Arizona in Tucson. Following U.S. residency training, Dr. Enzler completed fellowship in Hematology and Oncology at Columbia University Medical Center, New York, where he worked on several research projects on gastrointestinal cancers. Dr. Enzler is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma. Dr. Enzler is board certified in Internal Medicine, Medical Oncology, and Hematology.

Christopher Sonnenday, M.D., M.H.S., is the Darrell A. Campbell, Jr, M.D., Collegiate Professor of Transplant Surgery at the University of Michigan and Transplant Center Director for University of Michigan Health. He serves as Executive Vice Chair of the Department of Surgery, Surgical Director of Living Donor Liver Transplantation, and Surgical Director of the Multidisciplinary Liver Tumor Program for Michigan Medicine. He is a Professor in the Department of Surgery, Section of Transplantation, and Professor of Health Management and Policy at the School of Public Health. Dr. Sonnenday received his medical degree from Vanderbilt University in 1997, and completed his General Surgery residency at the Johns Hopkins University in 2005. While a research fellow in transplantation from 2000 to 2003, he completed a Masters of Health Sciences in Clinical Investigation at the Bloomberg School of Public Health. After completion of his residency, Dr. Sonnenday continued at Johns Hopkins as a Fellow in Surgical Oncology and Instructor of Surgery until 2006, and he completed a fellowship in abdominal transplant surgery at the University of Michigan in 2008. His primary academic and research interests include the study of frailty in liver transplant candidates, machine perfusion in liver transplantation, the overlap of transplant and oncology, quality collaboratives in transplantation, and leadership development in academic surgery.Clinical Specialization: Dr. Sonnenday's clinical interests focus on liver transplantation, hepatobiliary and pancreatic surgery, and general surgery procedures in patients with advanced liver disease. He sees patients in the Multidisciplinary Liver Tumor Clinic at the University of Michigan Rogel Cancer Center and the Transplant Clinic at the Taubman Center. Dr. Sonnenday is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy. Dr. Sonnenday is board certified in Surgery.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Oxana Crysler is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Crysler is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Crysler is board certified in Medical Oncology.

Murwarid Assifi is a Surgical Oncologist practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 19 years. Dr. Assifi is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Small Bowel Resection. Dr. Assifi is board certified in American Board Of Surgery and American Board Of Surgery.

Mark Herman is a General Surgeon practicing medicine in Rochester Hills, Michigan. He has been practicing medicine for over 32 years. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Hernia, Ogilvie Syndrome, Retroperitoneal Inflammation, Hernia Surgery, and Small Bowel Resection. Dr. Herman is board certified in American Board Of Surgery. Dr. Herman is currently accepting new patients.

Matthew Cotant is a Hematologist and an Oncologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 25 years. Dr. Cotant is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Neuroendocrine Tumor, Lynch Syndrome, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Cotant is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Cotant is currently accepting new patients.

Jessica Fried is a Radiologist and an Interventional Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Fried is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Visceromegaly, Alcoholic Cirrhosis, Cholangiocarcinoma (Bile Duct Cancer), and Cirrhosis. Dr. Fried is board certified in Diagnostic Radiology.

Gregory Gustafson is a Radiation Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 39 years. Dr. Gustafson is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Anal Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Gustafson is board certified in American Board Of Radiology. Dr. Gustafson is currently accepting new patients.

Vandad Raofi is a Surgical Oncologist practicing medicine in Royal Oak, Michigan. Dr. Raofi is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Raofi is board certified in American Board Of Surgery. Dr. Raofi is currently accepting new patients.